Correlation Between CRISPR Therapeutics and Air Products

Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and Air Products at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and Air Products into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CRISPR Therapeutics AG and Air Products and, you can compare the effects of market volatilities on CRISPR Therapeutics and Air Products and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of Air Products. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and Air Products.

Diversification Opportunities for CRISPR Therapeutics and Air Products

0.38

Correlation Coefficient

CRISPR Therapeutics  Air Products

Weak diversification

The 3 months correlation between CRISPR and Air is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and Air Products and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Air Products and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with Air Products. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Air Products has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and Air Products go up and down completely randomly.

Pair Corralation between CRISPR Therapeutics and Air Products

Assuming the 90 days trading horizon CRISPR Therapeutics AG is expected to generate 4.83 times more return on investment than Air Products. However, CRISPR Therapeutics is 4.83 times more volatile than Air Products and. It trades about 0.37 of its potential returns per unit of risk. Air Products and is currently generating about 0.28 per unit of risk. If you would invest  3,840  in CRISPR Therapeutics AG on April 20, 2025 and sell it today you would earn a total of  1,710  from holding CRISPR Therapeutics AG or generate 44.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

CRISPR Therapeutics AG  vs.  Air Products and

CRISPR Therapeutics

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in CRISPR Therapeutics AG are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, CRISPR Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Air Products

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Air Products and are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Air Products may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Pair Trading with CRISPR Therapeutics and Air Products

The main advantage of trading using opposite CRISPR Therapeutics and Air Products positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, Air Products can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Air Products will offset losses from the drop in Air Products' long position.

The idea behind CRISPR Therapeutics AG and Air Products and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.